RS63806B1 - Derivati 2,4,6,7-tetrahidro-pirazolo[4,3-d]pirimidin-5-ona i srodna jedinjenja kao modulatori c5a receptora za lečenje vaskulitisa i inflamatornih bolesti - Google Patents
Derivati 2,4,6,7-tetrahidro-pirazolo[4,3-d]pirimidin-5-ona i srodna jedinjenja kao modulatori c5a receptora za lečenje vaskulitisa i inflamatornih bolestiInfo
- Publication number
- RS63806B1 RS63806B1 RS20221138A RSP20221138A RS63806B1 RS 63806 B1 RS63806 B1 RS 63806B1 RS 20221138 A RS20221138 A RS 20221138A RS P20221138 A RSP20221138 A RS P20221138A RS 63806 B1 RS63806 B1 RS 63806B1
- Authority
- RS
- Serbia
- Prior art keywords
- pyrazolo
- pyrimidin
- tetrahydro
- derivatives
- inflammatory diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP2018050598 | 2018-01-10 | ||
PCT/EP2019/050372 WO2019137927A1 (en) | 2018-01-10 | 2019-01-09 | 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-one derivatives and related compounds as c5a receptor modulators for treating vasculitis and inflammatory diseases |
EP19700269.4A EP3737684B1 (en) | 2018-01-10 | 2019-01-09 | 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-one derivatives and related compounds as c5a receptor modulators for treating vasculitis and inflammatory diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
RS63806B1 true RS63806B1 (sr) | 2023-01-31 |
Family
ID=65012016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20221138A RS63806B1 (sr) | 2018-01-10 | 2019-01-09 | Derivati 2,4,6,7-tetrahidro-pirazolo[4,3-d]pirimidin-5-ona i srodna jedinjenja kao modulatori c5a receptora za lečenje vaskulitisa i inflamatornih bolesti |
Country Status (29)
Country | Link |
---|---|
US (2) | US11608341B2 (sr) |
EP (1) | EP3737684B1 (sr) |
JP (1) | JP7014914B2 (sr) |
KR (1) | KR102574564B1 (sr) |
CN (1) | CN111566109B (sr) |
AR (1) | AR114564A1 (sr) |
AU (1) | AU2019207666B2 (sr) |
BR (1) | BR112020013788A2 (sr) |
CA (1) | CA3086310C (sr) |
CL (1) | CL2020001817A1 (sr) |
DK (1) | DK3737684T3 (sr) |
EA (1) | EA202091641A1 (sr) |
ES (1) | ES2933820T3 (sr) |
HR (1) | HRP20221449T1 (sr) |
HU (1) | HUE060515T2 (sr) |
IL (1) | IL275868B2 (sr) |
LT (1) | LT3737684T (sr) |
MA (1) | MA51558B1 (sr) |
MX (1) | MX2020007443A (sr) |
PH (1) | PH12020500583A1 (sr) |
PL (1) | PL3737684T3 (sr) |
PT (1) | PT3737684T (sr) |
RS (1) | RS63806B1 (sr) |
SG (1) | SG11202006490YA (sr) |
SI (1) | SI3737684T1 (sr) |
TW (1) | TWI774905B (sr) |
UA (1) | UA124694C2 (sr) |
WO (1) | WO2019137927A1 (sr) |
ZA (1) | ZA202004910B (sr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2933820T3 (es) * | 2018-01-10 | 2023-02-14 | Idorsia Pharmaceuticals Ltd | Derivados de 2,4,6,7-tetrahidro-pirazolo[4,3-d]pirimidina-5-ona y compuestos relacionados como moduladores del receptor c5a para el tratamiento de la vasculitis y las enfermedades inflamatorias |
JP7281469B2 (ja) * | 2018-01-19 | 2023-05-25 | イドーシア ファーマシューティカルズ リミテッド | C5a受容体調節剤 |
CA3087784A1 (en) * | 2018-01-19 | 2019-07-25 | Idorsia Pharmaceuticals Ltd | C5a receptor modulators |
MX2022000411A (es) * | 2019-07-09 | 2022-02-10 | Idorsia Pharmaceuticals Ltd | Composicion farmaceutica que comprende un compuesto de tetrahidropirazolopirimidinona. |
US11193891B2 (en) * | 2019-12-20 | 2021-12-07 | Robert Bosch Gmbh | Receptors and spacers for a fluorescence-based lead ion chemosensor |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2479930A1 (en) | 2002-03-28 | 2003-10-09 | Neurogen Corporation | Substituted tetrahydroisoquinolines as c5a receptor modulators |
AU2003269850A1 (en) * | 2002-10-08 | 2004-05-04 | Novo Nordisk A/S | Hemisuccinate salts of heterocyclic dpp-iv inhibitors |
WO2006042102A2 (en) * | 2004-10-05 | 2006-04-20 | Neurogen Corporation | Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds |
US9126939B2 (en) | 2010-06-24 | 2015-09-08 | Pingchen Fan | C5AR antagonists |
US8846656B2 (en) | 2011-07-22 | 2014-09-30 | Novartis Ag | Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators |
TWI657090B (zh) * | 2013-03-01 | 2019-04-21 | 英塞特控股公司 | 吡唑并嘧啶衍生物治療PI3Kδ 相關病症之用途 |
MX2016002544A (es) | 2013-09-04 | 2016-06-17 | Squibb Bristol Myers Co | Compuestos utiles como inmunomoduladores. |
PL3041827T3 (pl) | 2013-09-06 | 2018-09-28 | Aurigene Discovery Tech Limited | Pochodne 1,2,4-oksadiazolu jako immunomodulatory |
WO2015044900A1 (en) | 2013-09-27 | 2015-04-02 | Aurigene Discovery Technologies Limited | Therapeutic immunomodulating compounds |
EA201790369A1 (ru) * | 2014-09-16 | 2017-10-31 | Джилид Сайэнс, Инк. | Твердые формы модулятора толл-подобного рецептора |
WO2017034872A1 (en) | 2015-08-25 | 2017-03-02 | Janssen Pharmaceutica Nv | Indazole derivatives useful as cb-1 inverse agonists |
ES2933820T3 (es) * | 2018-01-10 | 2023-02-14 | Idorsia Pharmaceuticals Ltd | Derivados de 2,4,6,7-tetrahidro-pirazolo[4,3-d]pirimidina-5-ona y compuestos relacionados como moduladores del receptor c5a para el tratamiento de la vasculitis y las enfermedades inflamatorias |
JP7281469B2 (ja) | 2018-01-19 | 2023-05-25 | イドーシア ファーマシューティカルズ リミテッド | C5a受容体調節剤 |
CA3087784A1 (en) | 2018-01-19 | 2019-07-25 | Idorsia Pharmaceuticals Ltd | C5a receptor modulators |
MX2022000411A (es) | 2019-07-09 | 2022-02-10 | Idorsia Pharmaceuticals Ltd | Composicion farmaceutica que comprende un compuesto de tetrahidropirazolopirimidinona. |
-
2019
- 2019-01-09 ES ES19700269T patent/ES2933820T3/es active Active
- 2019-01-09 AU AU2019207666A patent/AU2019207666B2/en active Active
- 2019-01-09 EA EA202091641A patent/EA202091641A1/ru unknown
- 2019-01-09 SG SG11202006490YA patent/SG11202006490YA/en unknown
- 2019-01-09 EP EP19700269.4A patent/EP3737684B1/en active Active
- 2019-01-09 UA UAA202004963A patent/UA124694C2/uk unknown
- 2019-01-09 US US16/961,600 patent/US11608341B2/en active Active
- 2019-01-09 CA CA3086310A patent/CA3086310C/en active Active
- 2019-01-09 HU HUE19700269A patent/HUE060515T2/hu unknown
- 2019-01-09 TW TW108100804A patent/TWI774905B/zh active
- 2019-01-09 WO PCT/EP2019/050372 patent/WO2019137927A1/en unknown
- 2019-01-09 PT PT197002694T patent/PT3737684T/pt unknown
- 2019-01-09 JP JP2020538035A patent/JP7014914B2/ja active Active
- 2019-01-09 PL PL19700269.4T patent/PL3737684T3/pl unknown
- 2019-01-09 MX MX2020007443A patent/MX2020007443A/es unknown
- 2019-01-09 RS RS20221138A patent/RS63806B1/sr unknown
- 2019-01-09 MA MA51558A patent/MA51558B1/fr unknown
- 2019-01-09 CN CN201980007596.9A patent/CN111566109B/zh active Active
- 2019-01-09 AR ARP190100043A patent/AR114564A1/es unknown
- 2019-01-09 DK DK19700269.4T patent/DK3737684T3/da active
- 2019-01-09 LT LTEPPCT/EP2019/050372T patent/LT3737684T/lt unknown
- 2019-01-09 KR KR1020207022343A patent/KR102574564B1/ko active IP Right Grant
- 2019-01-09 HR HRP20221449TT patent/HRP20221449T1/hr unknown
- 2019-01-09 SI SI201930400T patent/SI3737684T1/sl unknown
- 2019-01-09 BR BR112020013788-0A patent/BR112020013788A2/pt unknown
-
2020
- 2020-07-06 IL IL275868A patent/IL275868B2/en unknown
- 2020-07-07 PH PH12020500583A patent/PH12020500583A1/en unknown
- 2020-07-08 CL CL2020001817A patent/CL2020001817A1/es unknown
- 2020-08-07 ZA ZA2020/04910A patent/ZA202004910B/en unknown
-
2022
- 2022-12-20 US US18/084,911 patent/US20230192708A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202004910B (en) | 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-one derivatives and related compounds as c5a receptor modulators for treating vasculitis and inflammatory diseases | |
HK1258157A1 (zh) | 作為jak抑制劑的吡唑並[1,5-a]吡嗪-4-基衍生物 | |
IL270909A (en) | Imidazo[1,2-a]pyrazine modulators of the adenosine a2a receptor | |
ZA201902562B (en) | Pyrazolo [1,5-a]pyridine derivatives and their use as pesticides | |
LT3107914T (lt) | Pirazolo[1,5-a]pirimidin-5,7-diamino junginiai kaip cdk inhibitoriai ir jų terapinis panaudojimas | |
IL283149A (en) | Inhibitors of HPK1 and their use in the treatment of cancer | |
IL287168A (en) | Kit of pyrrolotriazine derivatives for the treatment of diseases mediated by pdgfra | |
LT3500571T (lt) | Imidazo[1,2-a]piridino junginiai, juos apimančios kompozicijos, ligų gydymo būdai juos panaudojant, ir jų paruošimo būdai | |
DK3177627T3 (da) | Imidazo[1,2-a]-pyrazolo[4,3-e]-pyrimidin-4-on-derivater med pde1-hæmmende aktivitet | |
FI3697784T5 (fi) | Imidatso[4,5-b]pyridiiniyhdisteet ja niiden farmaseuttiset koostu- mukset tulehduksellisten häiriöiden hoitoa varten | |
PL3277687T3 (pl) | Pochodne 7-(morfolin-4-ylo)pirazolo[1,5-a]pirymidyny użyteczne do leczenia chorób immunologicznych lub zapalnych lub nowotworów | |
IL267801B1 (en) | Process for the preparation of 3-disubstituted 5-amino-h6-thiazolo[5,4-d]pyrimidine-7,2-dione compounds | |
IL253427B (en) | The result of pyrazolo[3,4-d]pyrimidine and its use in the treatment of Jericho rose | |
HK1257427A1 (zh) | 用於製備2-吡唑並[1,5-a]吡嗪-2-基吡啶並[1,2-a]嘧啶-4-酮的方法 |